Search Results
-
Post
Anthem Inc. Issues Positive Coverage Decision For Optune in Newly Diagnosed Glioblastoma
...benefits for 14.5 million and 6 million lives, respectively – offer coverage of Optune for members who have recurrent GBM. Additional commercial payers that offer positive coverage policies for Optune...
-
Post
Novocure Announces Commercial Launch of Optune (the NovoTTF-100A System) in Japan
...Japan, http://www.optune.com/japan. The website provides a one-stop resource in Japanese for healthcare professionals seeking information on Optune for the treatment of recurrent glioblastoma. “We are honored to be working with...
-
Post
Novocure Announces Japanese Approval of Optune (the NovoTTF-100A System) for Treatment of Recurrent Glioblastoma
...the MHLW to allow recurrent GBM patients rapid access and full reimbursement for Optune.” “We believe that Optune is an important new treatment option for patients with recurrent GBM,” said...
-
Post
CMS Establishes 2019 Monthly Fee Schedule Amount for Optune®
...Use of Optune together with skull defects or bullet fragments has not been tested and may possibly lead to tissue damage or render Optune ineffective. Do not use the NovoTTF-100L...
-
Post
Novocure Files Premarket Approval Supplement Application With FDA for Second Generation Optune System
...FDA approval of the PMA supplement is required before Novocure can make the improved Optune system available to glioblastoma patients in the U.S. Optune is a portable, noninvasive device that...
-
Post
NCCN Guidelines Recommend Optune as a Standard Treatment Option for Newly Diagnosed Glioblastoma
...status, indicating uniform consensus among panel members to add Optune to the guidelines for newly diagnosed GBM. Optune has been included in the NCCN Guidelines as a category 2B treatment...
-
Post
Novocure to Offer On Demand Optune Certification Training for the Radiation Oncology Community at ASTRO 2015
...learn more about Optune. Novocure will also host a company information session and sponsor an industry expert theatre to provide education on the newly diagnosed GBM indication for Optune, as...
-
Post
German Federal Joint Committee Announces Decision to Support a Clinical Trial to Study Optune® for the Treatment of Newly Diagnosed Glioblastoma
...Optune for trial patients. “The decision by the G-BA to study Optune in combination with radiation therapy for the treatment of newly diagnosed GBM will provide valuable data on the...
-
Post
Novocure’s Optune Now Available at More Than 360 Cancer Treatment Centers in the U.S.
...also can prescribe Optune to GBM patients. Optune is a medical device used to deliver Tumor Treating Fields to disrupt cancer cell division and cause cancer cell death. Physicians must...
-
Post
Novocure™ Announces National Reimbursement for Optune® in Austria
...please visit www.novocure.com or follow us at www.twitter.com/novocure. About Optune In the United States, Optune is intended as a treatment for adult patients (22 years of age or older) with...